Yüklüyor......
Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin
BACKGROUND: Treatment with daunorubicin (DNR) in acute myeloid leukemia is moderately effective and associated with significant side effects, including cardiac toxicity. We recently developed a nanomicellar formulation of DNR that specifically targets acute myeloid leukemia stem cells. MATERIALS &am...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4167557/ https://ncbi.nlm.nih.gov/pubmed/24628688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.14.44 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|